Company Data
Design Therapeutics Inc.
Ticker
DSGN
Current Price
$12.57 -0.32%
Market Cap
$785.1M
Price Target
Refer to Report
Volume
468.2K
52wk Range
$3.76 - $17.25
Overview
Design Therapeutics Inc is a preclinical-stage biopharmaceutical company. It is a pioneering novel small-molecule therapeutic candidate, called gene-targeted chimera, that are designed to be disease-modifying and target the underlying cause of inherited nucleotide repeat expansion diseases.